Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations

Autor: Aurélie Courtin, Patricia Forgez, Myriam Vilasco, Justine Hugon-Rodin, Pascal Pujol, Najat Mourra, Muriel Perrault de Jotemps, Laudine Communal, Suzette Delaloge, Jean Feunteun, Marc Chaouat, Anne Gompel, Marie-Pierre Chauvet, Najiba Lahlou, Morwenna Le Guillou

Publikováno v: Oncotarget
Oncotarget, 2016, 7 (29), pp.45317-45330. ⟨10.18632/oncotarget.9638⟩
Oncotarget, Impact journals, 2016, 7 (29), pp.45317-45330. ⟨10.18632/oncotarget.9638⟩

// Laudine Communal 1 , Myriam Vilasco 1, * , Justine Hugon-Rodin 1, 2, * , Aurelie Courtin 1 , Najat Mourra 3 , Najiba Lahlou 4 , Morwenna Le Guillou 5 , Muriel Perrault de Jotemps 6 , Marie-Pierre Chauvet 7 , Marc Chaouat 8 , Pascal Pujol 9 , Jean

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8126ad5de38e7e40c2f3788f5b694a
https://hal.science/hal-01867496